Undertake the Future on “Advanced Therapies” !

Gene cell therapy and regenerative medicine for practical use are actively R&Ding at universities and pharmaceutical companies as new therapies.
Tokiwa-Bio Inc., developed a safe and stable gene expression technology with new approaches by transferring technology from AIST.
Stealth RNA Vector(SRV) enable highly efficient and stable expression of multiple genes and large genes in the cytoplasm, which have been researched and developed as technologies necessary for highly safe gene cell therapy and regenerative medicine.